Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Lymphoma 113Lymphoma, Non-Hodgkin 108Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Large B-Cell, Diffuse 85Lymphoma, Follicular 70Hodgkin Disease 54Burkitt Lymphoma 53Multiple Myeloma 52Lymphoma, B-Cell 52Recurrence 47Lymphoma, Mantle-Cell 46Leukemia, Myeloid, Acute 44Leukemia 40Neoplasms 35Hematologic Neoplasms 32Myelodysplastic Syndromes 29Lymphoma, B-Cell, Marginal Zone 26Waldenstrom Macroglobulinemia 22Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, T-Cell 19Leukemia, B-Cell 17Lymphoma, T-Cell, Peripheral 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Lymphoma, Large-Cell, Anaplastic 15Sarcoma 14Leukemia, Biphenotypic, Acute 13Mycosis Fungoides 11Melanoma 11Lymphoma, T-Cell, Cutaneous 10

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
B-cell Malignancies × Lymphoid × 30 days × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡